Tips for Regulatory Filing Impact of Scale-Up

Justifying Batch Size Increases in Regulatory Submissions: A Detailed Approach Increasing batch sizes during pharmaceutical manufacturing can be a complex issue, especially when it comes to regulatory filings. A lack…

The first indication that there may be an issue with process parameters during scale-up often comes from observing symptoms or signals on the production floor or within the lab. These…

During the scale-up process, several symptoms may indicate potential regulatory implications due to changes in process parameters. Common signs include:Click to read the full article.

In a recent scale-up scenario, a pharmaceutical company found discrepancies in product quality attributes between PPQ runs during scale-up and previous batches. Specific symptoms included inconsistent potency results, variability in…

The symptoms of regulatory non-compliance can often appear subtly at first. In this scenario, the manufacturing facility noted the following signals after a recent scale-up:Click to read the full article.

Identifying symptoms early is crucial in handling equipment changes during scale-up. Common signals that may indicate issues include:Click to read the full article.

Identifying potential regulatory complications during equipment changes involves close observation of specific symptoms or signals both on the production floor and in laboratory analysis. Common indicators of issues include:Click to…

The initial identification of potential stability issues typically comes from various signals, including:Click to read the full article.

Identifying symptoms from the production floor and laboratory testing is crucial in the early detection of stability issues. Key indicators often include:Click to read the full article.

Assessing the Effects of Packaging Scale-Up Changes on Regulatory Filings In pharmaceutical manufacturing, the transition from pilot to commercial-scale production often requires careful consideration of the regulatory landscape, particularly in…

Recognizing symptoms indicative of issues arising from packaging scale-up changes is crucial in early detection. Symptoms may vary based on the adjustments made and could include:Click to read the full…

Identifying the early signs of issues during scale-up is crucial for ensuring that deviations do not lead to significant regulatory non-compliance. Here are some common symptoms you might encounter:Click to…